Angiotensin-Converting Enzyme Inhibitor (ACEI)-Mediated Amelioration in Renal Fibrosis Involves Suppression of Mast Cell Degranulation
Background/Aims: The mechanism by which angiotensin-converting enzyme inhibitors (ACEIs) attenuate renal fibrosis has not been fully uncovered. Methods: Renal fibrosis in rats was triggered by unilateral ureteral obstruction (UUO) and treated with Enalapril. Results: Enalapril attenuated renal fibro...
Saved in:
Main Authors: | Nan Sun (Author), Lei Zhai (Author), Hui Li (Author), Li-Hua Shi (Author), Zhi Yao (Author), Bo Zhang (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2016-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development and validation of the angiotensin-converting enzyme inhibitor (ACEI) induced angioedema investigator rating scale and proposed discharge criteria
by: Nicola Bonner, et al.
Published: (2017) -
Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
by: Carlos P. Vio, et al.
Published: (2020) -
Angiotensin-converting enzyme inhibitors
by: David García Barreto, et al.
Published: (2014) -
Angiotensin-Converting Enzyme Inhibitor Does Not Suppress Renal Angiotensin II Levels in Angiotensin I-Infused Rats
by: Keisuke Ohnishi, et al.
Published: (2013) -
Purinergic Signaling in Mast Cell Degranulation and Asthma
by: Zhan-Guo Gao, et al.
Published: (2017)